CN108186749A - Treat Chinese medicine composition of cervical spondylosis and preparation method thereof - Google Patents
Treat Chinese medicine composition of cervical spondylosis and preparation method thereof Download PDFInfo
- Publication number
- CN108186749A CN108186749A CN201810131818.5A CN201810131818A CN108186749A CN 108186749 A CN108186749 A CN 108186749A CN 201810131818 A CN201810131818 A CN 201810131818A CN 108186749 A CN108186749 A CN 108186749A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- cervical spondylosis
- medicine composition
- weight
- chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 70
- 239000000203 mixture Substances 0.000 title claims abstract description 40
- 206010041591 Spinal osteoarthritis Diseases 0.000 title claims abstract description 29
- 208000036319 cervical spondylosis Diseases 0.000 title claims abstract description 29
- 208000005801 spondylosis Diseases 0.000 title claims abstract description 29
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims abstract description 15
- 244000020518 Carthamus tinctorius Species 0.000 claims abstract description 15
- 241000601164 Clematis orientalis Species 0.000 claims abstract description 15
- 241000218176 Corydalis Species 0.000 claims abstract description 15
- 241000195947 Lycopodium Species 0.000 claims abstract description 15
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 15
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 15
- 241000132171 Phryma leptostachya Species 0.000 claims abstract description 15
- 241000779819 Syncarpia glomulifera Species 0.000 claims abstract description 15
- 241000330755 Tylosema fassoglense Species 0.000 claims abstract description 15
- 235000018907 Tylosema fassoglense Nutrition 0.000 claims abstract description 15
- 239000001739 pinus spp. Substances 0.000 claims abstract description 15
- 229940036248 turpentine Drugs 0.000 claims abstract description 15
- 244000195896 dadap Species 0.000 claims abstract description 14
- 239000008280 blood Substances 0.000 claims abstract description 13
- 210000004369 blood Anatomy 0.000 claims abstract description 13
- 239000002994 raw material Substances 0.000 claims abstract description 13
- 240000007311 Commiphora myrrha Species 0.000 claims abstract description 12
- 235000006965 Commiphora myrrha Nutrition 0.000 claims abstract description 12
- 235000007265 Myrrhis odorata Nutrition 0.000 claims abstract description 12
- 239000000126 substance Substances 0.000 claims description 27
- 239000000706 filtrate Substances 0.000 claims description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 238000009835 boiling Methods 0.000 claims description 10
- 229940079593 drug Drugs 0.000 claims description 10
- 238000002156 mixing Methods 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 7
- 238000007654 immersion Methods 0.000 claims description 6
- 239000002775 capsule Substances 0.000 claims description 2
- 239000006072 paste Substances 0.000 claims description 2
- 239000006187 pill Substances 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 241000345998 Calamus manan Species 0.000 claims 1
- 241000287828 Gallus gallus Species 0.000 claims 1
- 235000012950 rattan cane Nutrition 0.000 claims 1
- 239000002893 slag Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 15
- 230000001225 therapeutic effect Effects 0.000 abstract description 12
- 208000002193 Pain Diseases 0.000 abstract description 10
- 210000003205 muscle Anatomy 0.000 abstract description 7
- 230000001737 promoting effect Effects 0.000 abstract description 6
- 210000000988 bone and bone Anatomy 0.000 abstract description 5
- 230000017531 blood circulation Effects 0.000 abstract description 4
- 230000008961 swelling Effects 0.000 abstract description 4
- 241000721047 Danaus plexippus Species 0.000 abstract description 3
- 210000004204 blood vessel Anatomy 0.000 abstract description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- 235000019441 ethanol Nutrition 0.000 description 6
- 206010028836 Neck pain Diseases 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 208000002173 dizziness Diseases 0.000 description 4
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 2
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 239000013049 sediment Substances 0.000 description 2
- 201000005671 spondyloarthropathy Diseases 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 241000167562 Pittosporum tobira Species 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 235000021270 cold food Nutrition 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 239000010218 duhuo jisheng Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000010248 fenbid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000003950 pathogenic mechanism Effects 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/716—Clematis (leather flower)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/238—Saposhnikovia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/24—Apocynaceae (Dogbane family), e.g. plumeria or periwinkle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/254—Acanthopanax or Eleutherococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/26—Aristolochiaceae (Birthwort family), e.g. heartleaf
- A61K36/264—Aristolochia (Dutchman's pipe)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/486—Millettia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to Chinese medicine preparation technical fields, disclose a kind of Chinese medicine composition and preparation method for treating cervical spondylosis, which is made of the raw material of following portions by weight：Berba aristolochiae mollissimae 10~20, Radix Angelicae Pubescentis 10~20, turpentine 30~40, lycopodium calvatum 10~20, windproof 20~30, Caulis Spatholobi 9~19, Rhizoma Chuanxiong 30~40, cortex acanthopanacis 10~20, the root of Chinese clematis 10~20, Radix Notoginseng 10~20, safflower 10~20, lopseed 10~20, myrrh 10~20, caulis trachelospermi 20~30, erythrina bark 10~20, corydalis tuber 20~30, champion bauhinia stem 30~40.Embodiment in the present invention is using Radix Angelicae Pubescentis, turpentine, lycopodium calvatum, windproof, cortex acanthopanacis, the root of Chinese clematis, erythrina bark, champion bauhinia stem as monarch, using Caulis Spatholobi, Rhizoma Chuanxiong, Radix Notoginseng, safflower, corydalis tuber as minister, assistant is with berba aristolochiae mollissimae, lopseed, myrrh, make with caulis trachelospermi, above all taste medicine component compatibilities, science combines, mutually compatible phase is needed and is used, without obvious toxic-side effects, with promoting blood circulation and removing blood stasis, swelling and pain relieving, human synovial muscles and bones of losing blood is enable to conserve, blood vessels channels and collaterals are unobstructed, so that the therapeutic effect of cervical spondylosis is more preferable.
Description
Technical field
The present invention relates to Chinese medicine preparation technical field, more particularly to a kind of Chinese medicine composition for treating cervical spondylosis and its preparation
Method.
Background technology
Cervical spondylosis is impediment syndrome, the so-called numbness of the traditional Chinese medical science, that is, occludes obstructed meaning, and " not general rule pain ".Its principal causative is former
Cause：First, damage；Second is that it is attacked outside exopathogen, predominantly wind, cold, wet；Third, Wei Yang is not solid, opening of sweat pores rushes down or vim and vigour are insufficient or phase
Internal organs is answered to lie concealed the illness reason caused by venereal disease change (each positive unsaturated vapor of internal organs).Its pathomechanism is：It is attacked in damage, exopathogen
Enter, under the insufficient pathogenic factor effect of healthy tendency, lead to stagnation of QI and blood, cause passages through which vital energy circulates qi and blood obstruction not smooth, with muscle, muscles and bones, pass
Section is ached, it is numb, weigh, joint stuffiness is main clinic symptoms.Its Etiological because of Shen controls bone, also has outer excessive in kidney
Leaching is attacked, caused by main long-term drinking eats the cold food of raw food, because kidney is afraid of to tremble with fear.Older more of morbidity crowd, with body
It is immune related.
The common drug for the treatment of cervical spondylosis can be divided into two major class of Western medicine and Chinese medicine at present, wherein, Western medicine has antalgesic, such as
Aspirin, brufen, Fenbid etc.；Adjusting nervous system trophism medicine has vitamin B1, vitamin B12, oryzanol, thorn
Slender acanthopanax piece, brain tonic mixture etc., these Western medicine can play the role for the treatment of pain, but not play effective radical cure effect.
Common Chinese patent drug has rheumatic cold pain piece, blood-nourishing honor muscle piece, GUXIAN PIAN, bony spur tablet, cervicodynia piece, Jingfukang, medicine xiaolingxian neck, neck that must answer
Deng.Common Chinese medicinal formulae has duhuo jisheng decoction, Taohong Siwu Tang, spur soup, stretches muscle blood activating decoction etc., these Chinese patent drugs or prescription
There is certain therapeutic effect to cervical spondylosis, but curative effect is slow, therapeutic effect is not highly satisfactory.
In conclusion at present it is urgent to provide a kind of to treating the Chinese medicine composition that cervical spondylosis curative effect is fast, therapeutic effect is good.
Invention content
The embodiment of the present invention is designed to provide a kind of Chinese medicine composition for treating cervical spondylosis and preparation method thereof so that
The therapeutic effect of cervical spondylosis is more preferable, and curative effect is faster.
In order to solve the above technical problems, the embodiment provides a kind of Chinese medicine composition for treating cervical spondylosis, by
The raw material of following portions by weight is made：Berba aristolochiae mollissimae 10~20, Radix Angelicae Pubescentis 10~20, turpentine 30~40, lycopodium calvatum 10~20, windproof 20
~30, Caulis Spatholobi 9~19, Rhizoma Chuanxiong 30~40, cortex acanthopanacis 10~20, the root of Chinese clematis 10~20, Radix Notoginseng 10~20, safflower 10~20,
Lopseed 10~20, myrrh 10~20, caulis trachelospermi 20~30, erythrina bark 10~20, corydalis tuber 20~30, champion bauhinia stem 30~40.
In addition, the embodiment of the present invention additionally provides a kind of preparation method for treating cervical spondylosis, include the following steps：
S1, each bulk pharmaceutical chemicals are weighed by above-mentioned parts by weight and are mixed；Add the water logging of 8~9 times of weight of material medicine
Bubble, the bulk pharmaceutical chemicals after being impregnated；
S2, the bulk pharmaceutical chemicals after the immersion are decocted to boiling, uses instead and be cooked by slow fire, filtered, obtain first time filtrate
And the dregs of a decoction；
S3, the water that the dregs of a decoction described in S2 are added to 6~8 times of bulk pharmaceutical chemicals again decoct to after boiling, use instead and be cooked by slow fire, mistake
Filter, obtains second of filtrate；
S4, the first time filtrate described in S2 and second of filtrate described in S3 are merged, mixing,.
The embodiment of the present invention is dispelled with Radix Angelicae Pubescentis, turpentine, lycopodium calvatum, windproof, cortex acanthopanacis, the root of Chinese clematis, erythrina bark, champion bauhinia stem except wind
Wet, warming channel and expelling cold, pain-relieving arthralgia dredging is monarch, using Caulis Spatholobi, Rhizoma Chuanxiong, Radix Notoginseng, safflower, corydalis tuber mass dissipating and swelling eliminating, wind-expelling pain-stopping as minister,
Assistant is made with caulis trachelospermi with berba aristolochiae mollissimae, lopseed, myrrh, more than all taste medicine component compatibilities, science combination, mutually compatible phase need and
With, no obvious toxic-side effects, there is promoting blood circulation and removing blood stasis, promoting circulation of blood qi-regulating, sensible active, swelling and pain relieving makes human synovial lose blood muscles and bones
It is conserved, blood vessels channels and collaterals are unobstructed, so that the therapeutic effect of cervical spondylosis is more preferable.
In addition, the Chinese medicine composition for the treatment of cervical spondylosis is made of the raw material of following portions by weight：Berba aristolochiae mollissimae 15~20, solely
Living 15~20, turpentine 25~40, lycopodium calvatum 5~20, windproof 15~30, Caulis Spatholobi 15~19, Rhizoma Chuanxiong 25~40, cortex acanthopanacis 5~
20, the root of Chinese clematis 5~20, Radix Notoginseng 5~20, safflower 5~20, lopseed 5~20, myrrh 5~20, caulis trachelospermi 25~30, erythrina bark 5
~20, corydalis tuber 25~30, champion bauhinia stem 35~40.
In addition, the Chinese medicine composition for the treatment of cervical spondylosis is made of the raw material of following portions by weight：Berba aristolochiae mollissimae 10, Radix Angelicae Pubescentis 10,
Turpentine 30, lycopodium calvatum 10, windproof 20, Caulis Spatholobi 9, Rhizoma Chuanxiong 30, cortex acanthopanacis 10, the root of Chinese clematis 10, Radix Notoginseng 10, safflower 10, lopseed
10, myrrh 10, caulis trachelospermi 20, erythrina bark 10, corydalis tuber 20, champion bauhinia stem 30.
In addition, the Chinese medicine composition is decoction, one kind in tablet, capsule, granule, pill, paste.
In addition, the decocting time in S2 and S3 is 30~50 minutes.
In addition, the decocting time in S2 and S3 is 40 minutes.
Specific embodiment
To make the object, technical solutions and advantages of the present invention clearer, various embodiments of the present invention will be carried out below
Detailed elaboration.However, it will be understood by those skilled in the art that in various embodiments of the present invention, in order to make reader more
The application is understood well and proposes many technical details.But even if without these technical details and based on following implementation
The various changes and modifications of example, can also realize the application technical solution claimed.
Embodiment 1
Chinese medicine composition in the present embodiment is made of the raw material of following portions by weight：Berba aristolochiae mollissimae 10, Radix Angelicae Pubescentis 10, turpentine
30, lycopodium calvatum 10, windproof 20, Caulis Spatholobi 9, Rhizoma Chuanxiong 30, cortex acanthopanacis 10, the root of Chinese clematis 10, Radix Notoginseng 10, safflower 10, lopseed 10 do not have
Medicine 10, caulis trachelospermi 20, erythrina bark 10, corydalis tuber 20, champion bauhinia stem 30.
Each bulk pharmaceutical chemicals in the present embodiment belong to common Chinese medicine, and can be obtained by buying.
Preferably, the Chinese medicine composition in the present embodiment can be decoction, wherein, prepare the method packet of the Chinese medicine composition
Include following steps：
S1, each bulk pharmaceutical chemicals are weighed by above-mentioned parts by weight and are mixed；Add the water logging of 8~9 times of weight of material medicine
Bubble, the bulk pharmaceutical chemicals after being impregnated；
S2, the bulk pharmaceutical chemicals after the immersion are decocted to boiling, uses instead and be cooked by slow fire, filtered, obtain first time filtrate
And the dregs of a decoction；
S3, the water that the dregs of a decoction described in S2 are added to 6~8 times of bulk pharmaceutical chemicals again decoct to after boiling, use instead and be cooked by slow fire, mistake
Filter, obtains second of filtrate；
S4, the first time filtrate described in S2 and second of filtrate described in S3 are merged, mixing,.
Preferably, the decocting time in S2 and S3 can be 40 minutes.
Compared with prior art, the embodiment of the present invention is with Radix Angelicae Pubescentis, turpentine, lycopodium calvatum, windproof, cortex acanthopanacis, the root of Chinese clematis, pittosporum tobira
Skin, champion bauhinia stem eliminate wind and clear damp, warming channel and expelling cold, pain-relieving arthralgia dredging are monarch, are disappeared with Caulis Spatholobi, Rhizoma Chuanxiong, Radix Notoginseng, safflower, corydalis tuber dissipating bind
Swollen, wind-expelling pain-stopping is minister, helps with berba aristolochiae mollissimae, lopseed, myrrh, makes with caulis trachelospermi, more than all taste medicine component compatibilities, science group
It closes, mutually compatible phase is needed and used, no obvious toxic-side effects, has promoting blood circulation and removing blood stasis, promoting circulation of blood qi-regulating, and sensible active, swelling and pain relieving makes
Human synovial muscles and bones of losing blood is conserved, and blood vessels channels and collaterals are unobstructed, so that the therapeutic effect of cervical spondylosis is more preferable.
Embodiment 2
Chinese medicine composition in the present embodiment is made of the raw material of following portions by weight：Berba aristolochiae mollissimae 10, Radix Angelicae Pubescentis 10, turpentine
30, lycopodium calvatum 10, windproof 20, Caulis Spatholobi 9, Rhizoma Chuanxiong 30, cortex acanthopanacis 10, the root of Chinese clematis 10, Radix Notoginseng 10, safflower 10, lopseed 10 do not have
Medicine 10, caulis trachelospermi 20, erythrina bark 10, corydalis tuber 20, champion bauhinia stem 30.
Each bulk pharmaceutical chemicals in the present embodiment belong to common Chinese medicine, and can be obtained by buying.
Preferably, the Chinese medicine composition in the present embodiment can be decoction, wherein, prepare the method packet of the Chinese medicine composition
Include following steps：
S1, each bulk pharmaceutical chemicals are weighed by above-mentioned parts by weight and are mixed；Add the water logging of 8~9 times of weight of material medicine
Bubble, the bulk pharmaceutical chemicals after being impregnated；
S2, the bulk pharmaceutical chemicals after the immersion are decocted to boiling, uses instead and be cooked by slow fire, filtered, obtain first time filtrate
And the dregs of a decoction；
S3, the water that the dregs of a decoction described in S2 are added to 6~8 times of bulk pharmaceutical chemicals again decoct to after boiling, use instead and be cooked by slow fire, mistake
Filter, obtains second of filtrate；
S4, the first time filtrate described in S2 and second of filtrate described in S3 are merged, mixing,.
Preferably, the decocting time in S2 and S3 can be 30 minutes.
Embodiment 3
Chinese medicine composition in the present embodiment is made of the raw material of following portions by weight：Berba aristolochiae mollissimae 10, Radix Angelicae Pubescentis 10, turpentine
30, lycopodium calvatum 10, windproof 20, Caulis Spatholobi 9, Rhizoma Chuanxiong 30, cortex acanthopanacis 10, the root of Chinese clematis 10, Radix Notoginseng 10, safflower 10, lopseed 10 do not have
Medicine 10, caulis trachelospermi 20, erythrina bark 10, corydalis tuber 20, champion bauhinia stem 30.
Each bulk pharmaceutical chemicals in the present embodiment belong to common Chinese medicine, and can be obtained by buying.
Preferably, the Chinese medicine composition in the present embodiment can be decoction, wherein, prepare the method packet of the Chinese medicine composition
Include following steps：
S1, each bulk pharmaceutical chemicals are weighed by above-mentioned parts by weight and are mixed；Add the water logging of 8~9 times of weight of material medicine
Bubble, the bulk pharmaceutical chemicals after being impregnated；
S2, the bulk pharmaceutical chemicals after the immersion are decocted to boiling, uses instead and be cooked by slow fire, filtered, obtain first time filtrate
And the dregs of a decoction；
S3, the water that the dregs of a decoction described in S2 are added to 6~8 times of bulk pharmaceutical chemicals again decoct to after boiling, use instead and be cooked by slow fire, mistake
Filter, obtains second of filtrate；
S4, the first time filtrate described in S2 and second of filtrate described in S3 are merged, mixing,.
Preferably, the decocting time in S2 and S3 can be 50 minutes.
Embodiment 4
Chinese medicine composition in the present embodiment is made of the raw material of following portions by weight：Berba aristolochiae mollissimae 20, Radix Angelicae Pubescentis 20, turpentine
40, lycopodium calvatum 20, windproof 30, Caulis Spatholobi 19, Rhizoma Chuanxiong 40, cortex acanthopanacis 20, the root of Chinese clematis 20, Radix Notoginseng 20, safflower 20, lopseed 20,
Myrrh 20, caulis trachelospermi 30, erythrina bark 20, corydalis tuber 30, champion bauhinia stem 40.
Each bulk pharmaceutical chemicals in the present embodiment belong to common Chinese medicine, and can be obtained by buying.
Preferably, the Chinese medicine composition in the present embodiment can be paste, wherein, prepare the method packet of the Chinese medicine composition
Include following steps：
S1, it each bulk pharmaceutical chemicals is weighed by above-mentioned parts by weight and are mixed is decocted, decocted rear liquid and concentrated,
It is 1 to be concentrated into proportion：1.3 concentration, cooling；
S2, the ethyl alcohol that 2 times are added in into mixture after cooling, are uniformly mixed, stand, make its precipitation；
S3, next day take supernatant；Sediment is merged with filtrate, is recovered under reduced pressure with 60% a small amount of ethyl alcohol wash clean, washing lotion
It after ethyl alcohol, when being concentrated into certain concentration, stands, filtering, filtrate low-temperature evaporation to paste, adds in other auxiliary materials, modulation is equal
It is even, you can be applied on medical adhesive tape to get to the ointment plaster of above-mentioned Chinese medicine composition.
Embodiment 5
Chinese medicine composition in the present embodiment is made of the raw material of following portions by weight：Berba aristolochiae mollissimae 15, Radix Angelicae Pubescentis 15, turpentine
25, lycopodium calvatum 5, windproof 15, Caulis Spatholobi 15, Rhizoma Chuanxiong 25, cortex acanthopanacis 5, the root of Chinese clematis 5, Radix Notoginseng 5, safflower 5, lopseed 5, myrrh 5,
Caulis trachelospermi 25, erythrina bark 5, corydalis tuber 25, champion bauhinia stem 35.
Each bulk pharmaceutical chemicals in the present embodiment belong to common Chinese medicine, and can be obtained by buying.
Preferably, the Chinese medicine composition in the present embodiment can be tablet, wherein, prepare the method packet of the Chinese medicine composition
Include following steps：
S1, each bulk pharmaceutical chemicals are weighed by above-mentioned parts by weight and are mixed, water is added to be decocted；
S2, the liquid after decocting is concentrated, is concentrated into a certain concentration (proportion 1：1 or so), cold rear 2 times of addition is put
Ethyl alcohol, abundant mixing stands overnight, and makes its precipitation；
S3, next day take the supernatant (filtering when necessary) of S2, and sediment is cleaned with a small amount of 60% ethyl alcohol, and washing lotion is closed with filtrate
And after ethyl alcohol is recovered under reduced pressure, it is to be concentrated to a certain concentration when a certain amount of water mixings is added to stand certain time, precipitation is made to filter completely
It crosses；
S4, by the filtrate low-temperature evaporation in S3 to paste, add in suitable auxiliary material in powdered extract powder, after mixing,
It pressurizes into gradually whole to satisfactory granularity, carries out tabletting to get tablet.
Embodiment 6：Clinical trial
1. general information
200 patient with cervical Spondylopathy are chosen, are met《New Chinese medicine treats the guideline of clinical investigations of cervical spondylosis》About
The diagnostic criteria of " cervical spondylosis ".It is randomly divided into two groups, treatment group 100, control group 100, two groups of patient ages, gender, diseases
There are the data such as number of cases, incidence, sign in feelings weight and symptom, are statistically analyzed, there was no significant difference (P>0.05), have
Comparativity.
2. therapeutic rules and medication
The Chinese medicine composition of the decoction dosage form of the embodiment of the present invention 1 is taken by treatment group, three times a day, each taking 200-
300ml, one week is 1 course for the treatment of, counts curative effect after two courses for the treatment of in 2 week of continuous use.Control group takes cervicodynia piece, and (Shandong is bright
Benevolence Fu Ruida pharmaceutical Co. Ltds produce) one time 4,3 times on the one, two weeks 1 courses for the treatment of, 4 week of continuous use, after two courses for the treatment of
Count curative effect.
3. criterion of therapeutical effect
Reference《New Chinese medicine treats the guideline of clinical investigations of cervical spondylosis》Standard, dizziness, cervicodynia and its related disease
Shape all disappears, and does not influence activity and work, and follow-up 3 months is clinical recovery without recurrence；Dizziness, cervicodynia and related symptoms base
This disappearance only has mild in tired or Changes in weather, and functional rehabilitation does not influence daily life or work, is effective；It is dizzy
Dizzy, cervicodynia and its related symptoms and sign make moderate progress, but unstable condition, have recurrence after drug withdrawal, have an impact to heavy work, are
Effectively；Clinical symptoms and sign is unchanged or anti-exacerbation, are invalid.
4. the therapeutic effect of two groups of patient with cervical Spondylopathy compares
Table 1：The therapeutic effect for the treatment of group cervical vertebra patient
Table 2：The therapeutic effect of control group cervical vertebra patient
In addition, by observation, there is adverse reaction without an example in above-mentioned 100 treatment group subjects, therefore the embodiment of the present invention 1
Chinese medicine composition without incompatibility, there is no any side effects.
5. experiment conclusion
Chinese medicine composition component science in the embodiment of the present invention, abundant raw material is cheap, reasonable compatibility, props up mutually
Hold, have effects that promoting blood circulation, tonify the liver and kidney, dispelling wind and eliminating dampness, removing blood stasis and analgesics, can effective for treat cervical spondylosis, curative effect
It is good, and drug safety, high efficiency have practical clinical meaning and very strong practical value up to more than 98%.
Likewise, the Traditional Chinese medicine composition paste and tablet to 4 and 5 gained treatment cervical spondylosis of embodiment have also been made accordingly
The effect of efficacy assessments are tested, result of the test and embodiment 1 evaluation test result is not made to apply herein to state without significant difference.
It will be understood by those skilled in the art that the various embodiments described above are to realize specific embodiments of the present invention, and
In practical applications, can to it, various changes can be made in the form and details, without departing from the spirit and scope of the present invention.
Claims (7)
1. a kind of Chinese medicine composition for treating cervical spondylosis, which is characterized in that be made of the raw material of following portions by weight：Berba aristolochiae mollissimae 10
~20, Radix Angelicae Pubescentis 10~20, turpentine 30~40, lycopodium calvatum 10~20, windproof 20~30, Caulis Spatholobi 9~19, Rhizoma Chuanxiong 30~40, five
Add skin 10~20, the root of Chinese clematis 10~20, Radix Notoginseng 10~20, safflower 10~20, lopseed 10~20, myrrh 10~20, caulis trachelospermi
20~30, erythrina bark 10~20, corydalis tuber 20~30, champion bauhinia stem 30~40.
2. the Chinese medicine composition for the treatment of cervical spondylosis according to claim 1, which is characterized in that in the treatment cervical spondylosis
Drug composition is made of the raw material of following portions by weight：Berba aristolochiae mollissimae 15~20, Radix Angelicae Pubescentis 15~20, turpentine 25~40, lycopodium calvatum 5~
20, windproof 15~30, Caulis Spatholobi 15~19, Rhizoma Chuanxiong 25~40, cortex acanthopanacis 5~20, the root of Chinese clematis 5~20, Radix Notoginseng 5~20, safflower 5
~20, lopseed 5~20, myrrh 5~20, caulis trachelospermi 25~30, erythrina bark 5~20, corydalis tuber 25~30, champion bauhinia stem 35~
40。
3. the Chinese medicine composition for the treatment of cervical spondylosis according to claim 1, which is characterized in that in the treatment cervical spondylosis
Drug composition is made of the raw material of following portions by weight：Berba aristolochiae mollissimae 10, Radix Angelicae Pubescentis 10, turpentine 30, lycopodium calvatum 10, windproof 20, chicken blood
Rattan 9, Rhizoma Chuanxiong 30, cortex acanthopanacis 10, the root of Chinese clematis 10, Radix Notoginseng 10, safflower 10, lopseed 10, myrrh 10, caulis trachelospermi 20, erythrina bark 10,
Corydalis tuber 20, champion bauhinia stem 30.
4. the Chinese medicine composition for the treatment of cervical spondylosis according to any one of claims 1 to 3, which is characterized in that the Chinese medicine
Composition is decoction, one kind in tablet, capsule, pill, paste.
5. a kind of preparation method for the Chinese medicine composition for treating cervical spondylosis, which is characterized in that include the following steps：
S1：Each bulk pharmaceutical chemicals are weighed by above-mentioned parts by weight and are mixed；The water of 8~9 times of weight of material medicine is added to impregnate, is obtained
Bulk pharmaceutical chemicals after to immersion；
S2：Bulk pharmaceutical chemicals after the immersion are decocted to boiling, uses instead and is cooked by slow fire, filters, obtains first time filtrate and medicine
Slag；
S3：The dregs of a decoction described in S2 are added to the water of 6~8 times of bulk pharmaceutical chemicals again, decocts to after boiling, uses instead and be cooked by slow fire, filter, obtain
To second of filtrate；
S4：First time filtrate described in S2 and second of filtrate described in S3 are merged, mixing,.
6. preparation method according to claim 5, which is characterized in that the decocting time in the S2 and S3 is 30~50 points
Clock.
7. preparation method according to claim 6, which is characterized in that the decocting time in the S2 and S3 is 40 minutes.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810131818.5A CN108186749A (en) | 2018-02-09 | 2018-02-09 | Treat Chinese medicine composition of cervical spondylosis and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810131818.5A CN108186749A (en) | 2018-02-09 | 2018-02-09 | Treat Chinese medicine composition of cervical spondylosis and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108186749A true CN108186749A (en) | 2018-06-22 |
Family
ID=62593459
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810131818.5A Pending CN108186749A (en) | 2018-02-09 | 2018-02-09 | Treat Chinese medicine composition of cervical spondylosis and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108186749A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109985225A (en) * | 2019-05-10 | 2019-07-09 | 赵凌志 | Hundred mean longitude network pain stopping ointments and its manufacturing method |
| CN111569037A (en) * | 2020-06-12 | 2020-08-25 | 甘肃岷州康养医药科技有限公司 | Moxibustion liquid traditional Chinese medicine composition, preparation method and self-heating moxibustion sticker |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101185718A (en) * | 2007-11-14 | 2008-05-28 | 王淋 | Medicine for treating bone joint disease and its preparation method |
| CN106039231A (en) * | 2016-07-27 | 2016-10-26 | 桐城市泰安中药材种植专业合作社 | Traditional Chinese medicinal preparation for treating cervical spondylosis |
-
2018
- 2018-02-09 CN CN201810131818.5A patent/CN108186749A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101185718A (en) * | 2007-11-14 | 2008-05-28 | 王淋 | Medicine for treating bone joint disease and its preparation method |
| CN106039231A (en) * | 2016-07-27 | 2016-10-26 | 桐城市泰安中药材种植专业合作社 | Traditional Chinese medicinal preparation for treating cervical spondylosis |
Non-Patent Citations (2)
| Title |
|---|
| 张玲: "中药辨证配合牵引治疗神经根型颈椎病疗效观察", 《中医正骨》 * |
| 杨彩霞；等: "九龙藤中黄酮类化合物的研究", 《西北师范大学学报(自然科学版)》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109985225A (en) * | 2019-05-10 | 2019-07-09 | 赵凌志 | Hundred mean longitude network pain stopping ointments and its manufacturing method |
| CN111569037A (en) * | 2020-06-12 | 2020-08-25 | 甘肃岷州康养医药科技有限公司 | Moxibustion liquid traditional Chinese medicine composition, preparation method and self-heating moxibustion sticker |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103071128B (en) | Externally-applied plaster for curing dysmenorrhea | |
| CN103784769A (en) | Chinese herbal preparation for treating orthopedic diseases | |
| CN104013910A (en) | Traditional Chinese medicine composition for treating hypertension | |
| CN108186749A (en) | Treat Chinese medicine composition of cervical spondylosis and preparation method thereof | |
| CN103919966B (en) | A kind of medicine treating acne | |
| CN103550688B (en) | A kind of Chinese medicine composition for the treatment of cardiopalmus | |
| CN104771652A (en) | Vertigo treating traditional Chinese medicine composition | |
| CN104587225A (en) | Traditional Chinese medicine composition for treating cervical spondylosis | |
| CN103830552A (en) | Traditional Chinese medicine composition for treating Meniere's disease | |
| CN102824421B (en) | Method for preparing Chinese medicinal lotion for treating surprised type closed fracture | |
| CN103550533B (en) | Chinese medicine composition for treating headache during menstruation | |
| CN102349957A (en) | Traditional Chinese medicine composition for treating prurigo | |
| CN101129718B (en) | Traditional Chinese medicine preparation for treating leuoderma | |
| CN105194227A (en) | Traditional Chinese medicine pills for treating leucoderma and preparation method of traditional Chinese medicine pills | |
| CN102614456B (en) | Preparation method of traditional Chinese medicine lotion for treating night-sweat-type ecthyma | |
| CN103961490A (en) | Compound medicine for treating wind-cold-dampness arthralgia and preparation method thereof | |
| CN104013718A (en) | Field thistle decoction traditional Chinese medicine preparation | |
| CN102824546B (en) | Method for preparing traditional Chinese medicinal lotion for treating closed fracture due to deficiency of kidney yin | |
| CN103285108B (en) | Chinese medicinal composition treating lumbago | |
| CN103386050B (en) | Chinese patent drug pill used for treating rheumatic ostealgia, cervical spondylosis and lumbar spondylosis | |
| CN102526678A (en) | Plaster for treating rheumatoid bone diseases | |
| CN103055172A (en) | Chinese medicinal composition for treating leucoderma | |
| CN102631633B (en) | Preparation method for traditional Chinese medicine wash lotion for treating constipation type acute lymphangitis | |
| CN102028810B (en) | Traditional Chinese medicine for treating lumbar intervertebral disc protrusion | |
| CN110841007B (en) | Traditional Chinese medicine composition for treating cerebral apoplexy sequela and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180622 |